References
- Kurosu M, Begari E. Bacterial protein kinase inhibitors. Drug Development Res 2010;71 168–187.
- Bekker OB, Elizarov SM, Alekseeva MT, Liubimova IK, Danilenko VN. [Ca2+-dependent modulation of antibiotic resistance in Streptomyces lividans 66 and Streptomyces coelicolor A3(2)]. Mikrobiologiia 2008;77:630–638.
- Petrícková K, Petrícek M. Eukaryotic-type protein kinases in Streptomyces coelicolor: variations on a common theme. Microbiology (Reading, Engl) 2003;149:1609–1621.
- Danilenko VN, Osolodkin DI, Lakatosh SA, Preobrazhenskaya MN, Shtil AA. Bacterial eukaryotic type serine-threonine protein kinases: from structural biology to targeted anti-infective drug design. Curr Top Med Chem 2011;11:1352–1369.
- Danilenko VN, Simonov AY, Lakatosh SA, Kubbutat MH, Totzke F, Schächtele C et al. Search for inhibitors of bacterial and human protein kinases among derivatives of diazepines[1,4] annelated with maleimide and indole cycles. J Med Chem 2008;51:7731–7736.
- Electronic Resources. Available at: http://pubchem.ncbi.nlm.nih.gov/assay. Accessed March 2012.
- Chioua M, Samadi A, Soriano E, Lozach O, Meijer L, Marco-Contelles J. Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors. Bioorg Med Chem Lett 2009;19:4566–4569.
- Traxler P, Bold G, Frei J, Lang M, Lydon N, Mett H et al. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem 1997;40:3601–3616.
- Parekh N, Maheria K, Patel P, Rathod M. Study on antibacterial activity for multidrug resistance stain by using phenyl pyrazolones substituted 3-amino-1H-pyrazolon[3,4-b]quinoline derivative in vitro condition. Inter J Pharm Tech Res 2011;3:540–548.
- Selvi ST, Nadaraj V, Mohan S, Sasi R, Hema M. Solvent free microwave synthesis and evaluation of antimicrobial activity of pyrimido[4,5-b]- and pyrazolo[3,4-b]quinolines. Bioorg Med Chem 2006;14:3896–3903.
- Amin MAS, Ismail MM, Barakat SES, Abdul-Rahman AAA, Bayomi AH, El-Gamal KMA. Synthesis and antimicrobial activity of some new quinoline and 1H-pyrazolo[3,4-b]quinoline derivatives. Bull Pharm Sci Assiut Univ 2004; 27:237–245.
- el-Sayed OA, Aboul-Enein HY. Synthesis and antimicrobial activity of novel pyrazolo[3,4-b]quinoline derivatives. Arch Pharm (Weinheim) 2001;334:117–120.
- Abdel-Rahman AE, Bakhite EA, Abdel-Moneam MI, Mohamed TA. Synthesis and antibacterial activities of some new thieno[2,3-b]quinolines. Phosphorus, Sulfur and Silicon 1992;73:219–227.
- Afghan A, Baradarani MM, Jouleb JA. Efficient syntheses of 1,3-unsubstituted 1H-pyrazolo[3,4-b]quinolines. ARKIVOC 2009:20–30.
- Geronikaki A, Druzhilovsky D, Zakharov A, Poroikov V. Computer-aided prediction for medicinal chemistry via the Internet. SAR QSAR Environ Res 2008;19:27–38.
- Chaczatrian K, Chaczatrian G, Danel A, Tomasik P. The synthesis of 4-aryl-1H-pyrazolo[3,4-b]quinolines by cyclization of 4-arylidenepyrazolin-5-ones with anilines. ARKIVOC 2001:63–69.
- Elnagdi MH, Abdel-Galil FM, Riad BY, Elgemei GEH. Recent development in chemistry of 3(5)-aminopyrazoles. Heterocycles 1983; 20:2437.
- Stadlbauer W, Hojas G. Synthesis of 4-azido-3-diazo-3H-3H-pyrazolo[3,4-b]quinoline from 3-amino-4-hydrazino-1H-pyrazolo[3,4-b]quinoline. J Chem Soc Perkin Trans I 2000:3085–3087.